Cardiovascular effects of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
The efficacy of tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, in improving metabolic parameters is well established in patients with type 2 diabetes and obesity. However, despite its rapidly expanding clinical use, the overall cardiova...